{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T19:56:16Z","timestamp":1776110176576,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thegreenjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.radonc.2016.11.013","type":"journal-article","created":{"date-parts":[[2016,11,29]],"date-time":"2016-11-29T09:18:33Z","timestamp":1480411113000},"page":"50-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Prophylactic treatment with a potent corticosteroid cream ameliorates radiodermatitis, independent of radiation schedule"],"prefix":"10.1016","volume":"122","author":[{"given":"Eva","family":"Ulff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Maroti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rgen","family":"Serup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula","family":"Falkmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2016.11.013_b0005","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/jnci\/94.15.1143","article-title":"Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer","volume":"94","author":"Whelan","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2016.11.013_b0010","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","article-title":"The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials","volume":"14","author":"Haviland","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2016.11.013_b0015","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2015.2590","article-title":"Differences in the acute toxic effects of breast radiotherapy by fractionation schedule: comparative analysis of physician-assessed and patient-reported outcomes in a large multicenter cohort","author":"Jagsi","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2016.11.013_b0020","first-page":"33","article-title":"Factors influencing the severity of radiation skin and oral mucosal reactions: development of a conceptual framework","volume":"11","author":"Porock","year":"2002","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1016\/j.radonc.2016.11.013_b0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0167-8140(03)00166-X","article-title":"Personal characteristics, therapy modalities and individual DNA repair capacity as predictive factors of acute skin toxicity in an unselected cohort of breast cancer patients receiving radiotherapy","volume":"69","author":"Twardella","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.11.013_b0030","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.radonc.2013.05.033","article-title":"A potent steroid cream is superior to emollients in reducing acute radiation dermatitis in breast cancer patients treated with adjuvant radiotherapy. A randomised study of betamethasone versus two moisturizing creams","volume":"108","author":"Ulff","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.11.013_b0035","unstructured":"Group ECO. Peformance status http:\/\/ecog-acrin.org\/resources\/ecog-performance-status, 2015."},{"key":"10.1016\/j.radonc.2016.11.013_b0040","unstructured":"Swedish Breast Cancer Group. Nationel guidelines for breast cancer, 2011."},{"key":"10.1016\/j.radonc.2016.11.013_b0045","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1001\/archderm.1988.01670060015008","article-title":"The validity and practicality of sun-reactive skin types I through VI","volume":"124","author":"Fitzpatrick","year":"1988","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.radonc.2016.11.013_b0050","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.11.013_b0055","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1754-9485.2010.02170.x","article-title":"Management of skin toxicity during radiation therapy: a review of the evidence","volume":"54","author":"Kumar","year":"2010","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.radonc.2016.11.013_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-198800365-00003","article-title":"Perspectives in corticosteroid research","volume":"36","author":"Topert","year":"1988","journal-title":"Drugs"},{"key":"10.1016\/j.radonc.2016.11.013_b0065","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/1523-1747.ep12260665","article-title":"Morphologic investigations on the rebound phenomenon after corticosteroid-induced atrophy in human skin","volume":"82","author":"Zheng","year":"1984","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.radonc.2016.11.013_b0070","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/1523-1747.ep12543603","article-title":"Corticosteroid atrophy in human skin. A study by light, scanning, and transmission electron microscopy","volume":"81","author":"Lehmann","year":"1983","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.radonc.2016.11.013_b0075","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1034\/j.1600-0846.2001.70203.x","article-title":"Corticosteroid-induced atrophy and barrier impairment measured by non-invasive methods in human skin","volume":"7","author":"Kolbe","year":"2001","journal-title":"Skin Res Technol"},{"key":"10.1016\/j.radonc.2016.11.013_b0080","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1269\/jrr.10169","article-title":"Association between skin phototype and radiation dermatitis in patients with breast cancer treated with breast-conserving therapy: suntan reaction could be a good predictor for radiation pigmentation","volume":"52","author":"Yamazaki","year":"2011","journal-title":"J Radiat Res"},{"key":"10.1016\/j.radonc.2016.11.013_b0085","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0167-8140(01)00327-9","article-title":"Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double-blind, randomized study","volume":"59","author":"Bostrom","year":"2001","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.11.013_b0090","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/jnci\/93.2.128","article-title":"Induction of p53 expression in skin by radiotherapy and UV radiation: a randomized study","volume":"93","author":"Ponten","year":"2001","journal-title":"J Natl Cancer Inst"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814016343997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814016343997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T05:26:29Z","timestamp":1536211589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814016343997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0167814016343997"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2016.11.013","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prophylactic treatment with a potent corticosteroid cream ameliorates radiodermatitis, independent of radiation schedule","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2016.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}